Skip to content
PubMed This is a summary of 85 peer-reviewed journal articles Updated
Hematology

Pure red-cell aplasia: A Patient Guide

At a Glance

Pure red-cell aplasia (PRCA) is a rare disorder in which the bone marrow nearly stops making red blood cells while white blood cells and platelets are often preserved. Diagnosis uses blood and marrow tests, and treatment targets the underlying cause.

Pure red-cell aplasia (PRCA) is a rare and highly selective disorder of the bone marrow where the body’s “blood factory” suddenly stops producing red blood cells [1]. While other types of bone marrow failure can affect your entire blood supply, PRCA is unique because it generally spares your white blood cells, which fight infection, and your platelets, which help your blood clot [2]. This means that your primary defense and repair systems are usually preserved in isolated PRCA, but they must still be monitored closely. Keep in mind that underlying conditions, such as Good syndrome, or the immunosuppressive treatments used for PRCA can compromise your immune system, making you more vulnerable to infection [3].

The condition is broadly divided into two forms based on its origin and the age at which it appears. Acquired PRCA most often affects adults and can occur suddenly, either as a primary autoimmune issue where the immune system mistakenly attacks the marrow, or as a secondary reaction to factors like a viral infection (such as Parvovirus B19), certain medications, or an underlying tumor of the thymus gland [4][5]. In contrast, Congenital PRCA encompasses inherited genetic conditions. The most common of these is Diamond-Blackfan Anemia (DBA), which is typically diagnosed in infancy or early childhood, though there are other rare genetic causes that require specialist evaluation and genetic counseling [6]. Both forms result in a state called severe hypoproliferative anemia, where the body fails to replace red blood cells as they naturally age out of circulation [7].

Confirming a diagnosis of PRCA requires a detailed look at both your circulating blood and the bone marrow itself. Doctors look for a specific signature: a critically low count of reticulocytes (young red blood cells) in the bloodstream and a bone marrow biopsy that shows a near-total absence of erythroid precursors, the “seed” cells that should grow into mature red blood cells [8][4]. This diagnostic process is essential not just to confirm the condition, but to act as a workup to find the specific trigger—whether it be an immune dysfunction, a viral “freeze” on production, or a genetic mutation—that will guide your treatment [9].

Because PRCA is cause-directed, your treatment plan will be tailored to the specific reason your marrow has stalled. For many adults, this involves medications that calm the immune system; for those with a viral trigger, it may involve providing the body with the antibodies it needs to clear the infection; and for children with DBA, the focus often begins with corticosteroids or regular blood transfusions [2][10]. While the road to recovery requires patience and frequent monitoring, PRCA is a treatable condition with established standards of care designed to support your body and protect your health while your marrow begins to work again [5].

Common questions in this guide

What is pure red-cell aplasia?
Pure red-cell aplasia (PRCA) is a rare bone marrow disorder in which production of new red blood cells nearly stops. In isolated PRCA, white blood cells and platelets are usually preserved, although the underlying condition or treatment can still increase infection risk.
What can cause pure red-cell aplasia?
In adults, acquired PRCA may be caused by an autoimmune attack, a viral infection such as Parvovirus B19, certain medicines, or a tumor of the thymus gland. Congenital PRCA results from inherited conditions, most commonly Diamond-Blackfan anemia.
How do doctors diagnose PRCA?
Doctors look for a very low reticulocyte count, meaning few young red blood cells are circulating, and a bone marrow biopsy showing very few or no cells that normally develop into red blood cells. Additional testing helps identify an immune, infectious, medication-related, or genetic cause.
How is pure red-cell aplasia treated?
Treatment is chosen according to the cause. It may include medicines that calm the immune system, antibody treatment for a viral trigger, or corticosteroids and blood transfusions for Diamond-Blackfan anemia; transfusions may also be used as supportive care.
Will PRCA affect my white blood cells and platelets?
In isolated PRCA, white blood cells and platelets are generally spared, so the problem is focused on red blood cell production. Your care team will still monitor your blood counts because associated conditions or treatment can increase infection risk.
Can pure red-cell aplasia be treated?
PRCA is treatable, but recovery depends on what stopped red blood cell production and may require frequent blood-count monitoring. Care may focus on clearing an infection, calming an immune response, treating an inherited condition, and supporting anemia while the marrow recovers.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Is my pure red-cell aplasia considered primary or secondary to an underlying cause?
  2. 2.Are my white blood cell and platelet counts being monitored to ensure this remains a selective red-cell issue?
  3. 3.How do you plan to differentiate the 'expected' fatigue of anemia from signs that I need a supportive transfusion?
  4. 4.What is our immediate goal for treatment—is it to clear a virus, treat an immune issue, or manage a genetic condition?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (10)
  1. 1

    Pure red cell aplasia: The second hundred years.

    Means RT

    The American journal of the medical sciences 2023; (366(3)):160-166 doi:10.1016/j.amjms.2023.06.009.

    PMID: 37327996
  2. 2

    Pure red cell aplasia.

    Means RT

    Hematology. American Society of Hematology. Education Program 2016; (2016(1)):51-56 doi:10.1182/asheducation-2016.1.51.

    PMID: 27913462
  3. 3

    Pure Red Cell Aplasia Caused by Azathioprine.

    Kounatidis D, Vallianou N, Daskalaki V, et al.

    Cardiovascular & hematological disorders drug targets 2020; (20(2)):164-165 doi:10.2174/1871529X18666180828145818.

    PMID: 30156166
  4. 4

    Hepatitis C Infection Associated with Acquired Pure Red Cell Aplasia.

    Teague D, Gurnari C, Awada H, et al.

    Tropical medicine and infectious disease 2022; (8(1)) doi:10.3390/tropicalmed8010008.

    PMID: 36668915
  5. 5

    [Pure red cell aplasia: Diagnosis, classification and treatment].

    Lobbes H

    La Revue de medecine interne 2023; (44(1)):19-26 doi:10.1016/j.revmed.2022.10.385.

    PMID: 36336519
  6. 6

    [Research Progress on Pathogenesis of Congenital Pure Red Cell Aplasia---Review].

    Liu WY, Wang HQ, Shao ZH

    Zhongguo shi yan xue ye xue za zhi 2021; (29(5)):1654-1657 doi:10.19746/j.cnki.issn.1009-2137.2021.05.045.

    PMID: 34627456
  7. 7

    Etiologies and Treatment Burden in Adult Patients with Pure Red Cell Aplasia: A Single-Center Experience and Review of Literature.

    Niparuck P, Kanoksil W, Wacharapornin P, et al.

    Anemia 2020; (2020()):4812759 doi:10.1155/2020/4812759.

    PMID: 32257434
  8. 8

    A nomogram model for predicting the efficacy of cyclosporine in patients with pure red cell aplasia.

    Yang L, Niu H, Zhang T, et al.

    Annals of hematology 2024; (103(6)):1877-1885 doi:10.1007/s00277-024-05636-9.

    PMID: 38308019
  9. 9

    Refractory anemia in human immunodeficiency virus: Expect the unexpected.

    Mirgh SP, Mishra VA, Shah VD, Sorabjee JS

    Journal of family medicine and primary care 2016; (5(3)):727-729 doi:10.4103/2249-4863.197288.

    PMID: 28217621
  10. 10

    Diagnosis, treatment, and surveillance of Diamond-Blackfan anaemia syndrome: international consensus statement.

    Wlodarski MW, Vlachos A, Farrar JE, et al.

    The Lancet. Haematology 2024; (11(5)):e368-e382 doi:10.1016/S2352-3026(24)00063-2.

    PMID: 38697731

This page explains pure red-cell aplasia for informational purposes only and is not medical advice. Your hematologist and care team can interpret your blood and bone marrow results and recommend treatment for your situation.

Get notified when new evidence is published on Pure red-cell aplasia.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.